logo
Select company
Select metric
$ -11.27MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
24
Sector
59
Industry
75
History
-
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 120.25K$ -11.39M$ -11.27M
3/31/2025$ 104.44K$ -9.38M$ -9.28M
12/31/2024$ 118.17K$ -7.32M$ -7.2M
9/30/2024$ 115.43K$ -5.8M$ -5.68M
6/30/2024$ 202.17K$ -4.83M$ -4.63M
3/31/2024$ 205.24K$ -5.44M$ -5.24M
12/31/2023$ 203.34K$ -6.11M$ -5.91M
9/30/2023$ 189.19K$ -6.71M$ -6.52M
6/30/2023$ 112.11K$ -7M$ -6.89M
3/31/2023$ 119.47K$ -7.02M$ -6.9M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) EBITDA stands at $ -3.97M.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average EBITDA has been $ -6.05M.
  • The median EBITDA for LEXARIA BIOSCIENCE CORP during this period was $ -6.22M
  • LEXARIA BIOSCIENCE CORP reached its highest EBITDA over the past 5 years at $ -2.38M.
  • The lowest EBITDA recorded by LEXARIA BIOSCIENCE CORP in the same timeframe $ -11.27M

LEXARIA BIOSCIENCE CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
BRTX : BIORESTORATIVE THERAPIES INC $ -10.44MIBIO : IBIO INC $ -17.04MERNA : ERNEXA THERAPEUTICS INC $ -37.86MICU : SEASTAR MEDICAL HOLDING CORP $ -14.63MRLYB : RALLYBIO CORP $ -41.54MLYRA : LYRA THERAPEUTICS INC $ -38.37MPULM : PULMATRIX INC $ -7.93MVYNE : VYNE THERAPEUTICS INC $ -38.52MAPRE : APREA THERAPEUTICS INC $ -14.83MMGRX : MANGOCEUTICALS INC $ -13.13M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for LEXARIA BIOSCIENCE CORP is calculated as follows: EBIT [ $ -4.08M ] + DepAmor [ $ 112.75K ]
(=) EBITDA [ $ -3.97M ]

LEXX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -11.27M

Minimum

Jun 30, 2025

$ -2.38M

Maximum

Mar 31, 2021

$ -6.05M

Average

$ -6.22M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M